 | Sangamo Therapeutics, Inc. | |||
| NMS : SGMO || Location: United States | ||||
$0.5+0.01 (+2.65%) |
0.76 M | 0.47 - 0.53 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 11.412 M |
| March 15, 2024 | 10.884 M |
| Feb. 29, 2024 | 10.062 M |
| Feb. 15, 2024 | 9.727 M |
| Jan. 31, 2024 | 9.981 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.26 | -0.34 | -30.12% |
| 09/30/2023 | -0.33 | -0.59 | -80.76% |
| 06/30/2023 | -0.35 | -0.66 | -88.95% |
| 03/31/2023 | -0.33 | 0.12 | 135.85% |
| 12/31/2022 | -0.37 | -0.32 | 12.85% |
SGMO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 203.668M | Shares Float | 165.084M |
| Short Float | 11.412M | Market Cap | 99.80M |
| Institution ownership | 49.94% | Insider ownership | 9.450% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.48 | Forward EPS | -0.27 |